ANN ARBOR, Mich., April 23, 2008 (PRIME NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM) will host two one-hour telephone Question & Answer sessions to provide further clarity on the proposal to amend the Company's Restated Articles of Incorporation to position the Company's Board of Directors to consider and execute a potential plan of action involving a reverse split of Aastrom's issued and outstanding common stock:
